FGF23 and cardiac hypertrophy: Moreover, such an elevation of cardiomyocyte-derived circulating FGF23 resulting from cardiac hypertrophy may not only alter phosphate homeostasis but also increase the overall metabolic burden, as well as hypertension and hemodynamic abnormalities.